Business Wire

Cala Trio is a Rising Standard of Care for the Treatment of Essential Tremor through Clinical Research and Industry Guidelines

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating pieces of news for the non-invasive ...
BioWorld

Cala Health releases real-world data on Cala Trio’s effectiveness in reducing tremors

In August, Cala Health Inc. reported results from its pivotal PROSPECT study showing significant improvement in hand tremors with use of its Cala Trio wearable neuromodulation therapy. Now the company ...
Business Wire

New Data Demonstrate How Cala Trio™ Enables a More Frequent Assessment of Hand Tremor Compared with In-Person Assessments in Patients with Essential Tremor and Supports ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announces new data confirming that in-person ...
Business Insider

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio(TM)

SANTA CLARA, Calif., Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 ...
BioWorld

Cala Health scoops up $50M in series C funding

Burlingame, Calif.-based Cala Health Inc., which is developing wearable therapies for chronic disease, completed a $50 million series C financing. The funds are earmarked for introducing the Cala Trio ...